{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:33Z","timestamp":1791235293379,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jjcc.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:36:01Z","timestamp":1699500961000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Heart failure management guidelines: New recommendations and implementation"],"prefix":"10.1016","volume":"83","author":[{"given":"Paul","family":"Heidenreich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2023.10.009_bb0005","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/ehf2.14321","article-title":"Trends in heart failure prevalence in Japan 2014-2019: a report from healthcare administration databases","volume":"10","author":"Zhang","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0010","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0015","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","article-title":"Prevalence, incidence and survival of heart failure: a systematic review","volume":"108","author":"Emmons-Bell","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0025","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.003116","article-title":"Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes","volume":"9","author":"Ho","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000811","article-title":"Mortality after admission for heart failure in the UK compared with Japan","volume":"5","author":"Nagai","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008687","article-title":"9-year trend in the management of acute heart failure in Japan: a report from the National Consortium of acute heart failure registries","volume":"7","author":"Shiraishi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0050","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jjcc.2023.10.009_bb0055","first-page":"00050","volume":"S1071-9164","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0060","article-title":"Clinical predictors of improvement in left ventricular ejection fraction in U.S. veterans with heart failure","volume":"19","author":"Nallamshetty","year":"2022","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jamacardio.2020.0898","article-title":"Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure","volume":"5","author":"Bassi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamacardio.2021.4585","article-title":"Evaluation of quality of care for US veterans with recent-onset heart failure with reduced ejection fraction","volume":"7","author":"Sandhu","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249711","article-title":"Actual state of \u201ctriple therapy\u201d for heart failure patients in eight regions of Japan: an analysis of a nationwide medical claims database","volume":"16","author":"Abe","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40801-022-00315-5","article-title":"Burden of repeated hospitalizations on patients with heart failure: an analysis of administrative and claims data in Japan","volume":"9","author":"Eguchi","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0100","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamacardio.2021.1437","article-title":"Cost-effectiveness of dapagliflozin for treatment of patients with heart failure with reduced ejection fraction","volume":"6","author":"Parizo","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0120","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamainternmed.2022.5010","article-title":"Cost-effectiveness of empagliflozin in patients with heart failure with preserved ejection fraction","volume":"182","author":"Zheng","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"issue":"81","key":"10.1016\/j.jjcc.2023.10.009_bb0130","first-page":"1076","article-title":"ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution set Oversight Committee","volume":"2023","author":"Writing Committee; Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cardfail.2016.12.006","article-title":"Baseline characteristics predict the presence of amyloid on endomyocardial biopsy","volume":"23","author":"Ton","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","article-title":"Haemodynamic-guided management of heart failure (GUIDEHF): a randomised controlled trial","volume":"398","author":"Lindenfeld","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0150","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0155","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"issue":"77","key":"10.1016\/j.jjcc.2023.10.009_bb0160","first-page":"e25","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint Committee on clinical practice guidelines","volume":"2021","author":"Writing Committee Members; Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0165","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ejhf.2860","article-title":"Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: a Bayesian meta-analysis","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0170","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0175","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0180","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association task force on performance measures and task force on practice guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cardfail.2021.12.017","article-title":"Economic issues in heart failure in the United States","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14319","article-title":"Comparison of patient self-reported health status with clinician-assigned New York heart association classification","volume":"3","author":"Tran","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cardfail.2008.01.014","article-title":"A comparison of patient and physician-rated New York heart association class in a community-based heart failure clinic","volume":"14","author":"Goode","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","article-title":"Comparison of New York heart association class and patient-reported outcomes for heart failure with reduced ejection fraction","volume":"6","author":"Greene","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0205","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2005.11.021","article-title":"Health status identifies heart failure outpatients at risk for hospitalization or death","volume":"47","author":"Heidenreich","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCHEARTFAILURE.111.964221","article-title":"Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial","volume":"5","author":"Rector","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002875","article-title":"Association of patient-reported health status with long-term mortality after transcatheter aortic valve replacement: report from the STS\/ACC TVT registry","volume":"8","author":"Arnold","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010280","article-title":"Impact of patient-reported outcome measurement in heart failure clinic on clinician health status assessment and patient experience: a substudy of the PRO-HF trial","volume":"16","author":"Sandhu","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0225","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0230","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0240","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0245","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart failure and a reduced ejection fraction?: a redefinition of evidence-based medicine","volume":"143","author":"McMurray","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0250","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2021.18","article-title":"The gap to fill: rationale for rapid initiation and optimal titration of comprehensive disease-modifying medical therapy for heart failure with reduced ejection fraction","volume":"7","author":"Brownell","year":"2021","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0255","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.healun.2017.02.010","article-title":"\u201cI need Help\u201d-a mnemonic to aid timely referral in advanced heart failure","volume":"36","author":"Baumwol","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0260","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000099","article-title":"2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology\/American Heart Association task force on performance measures","volume":"13","author":"Heidenreich","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0265","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005024","article-title":"Cluster randomized trial examining the impact of automated best practice alert on rates of implantable defibrillator therapy","volume":"12","author":"Lee","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0270","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/CIRCULATIONAHA.106.684753","article-title":"Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial","volume":"115","author":"Heidenreich","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2023.10.009_bb0275","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cardfail.2023.03.012","article-title":"Pharmacist- and nurse-led medical optimization in heart failure: a systematic review and meta-analysis","volume":"29","author":"Zheng","year":"2023","journal-title":"J Card Fail"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872300271X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872300271X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:09:57Z","timestamp":1760274597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872300271X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S091450872300271X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.10.009","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure management guidelines: New recommendations and implementation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}